RESUMEN
Bortezomib is a proteasome inhibitor demonstrating substantial activity in multiple myeloma. One of its key toxicities is peripheral neuropathy, which is reversible in most patients. The possibility that bortezomib might in rare cases induce severe neuropathies by auto-inflammatory mechanisms remains controversial. We report here the case of a 65-year-old female myeloma patient who was initially treated with bortezomib, doxorubicin, and dexamethasone (PAD). At the end of the second cycle of PAD, the patient presented with a rapid and severe onset of paresis of the left arm, accompanied by progressive sensory neuropathy and increasing neuropathic pain. After an extensive neurological work-up, including electrophysiological and laboratory evaluations as well as magnet resonance tomography imaging, we diagnosed an inflammatory autoimmune neuropathy, presumably induced by bortezomib, with accentuation of the left arm nerve plexus. We subsequently initiated regular treatment with polyvalent immunoglobulins, which gradually improved the neurological symptoms. In conclusion, the identification of an inflammatory autoimmune neuropathy, presumably associated with bortezomib, is a rare but important complication. An extensive neurological examination should be performed in patients who develop severe or unusual sensory or motor deficits under therapy with bortezomib, so as to differentiate autoimmune from toxic neuropathies, as therapeutic strategies differ for each.
Asunto(s)
Antineoplásicos , Enfermedades Autoinmunes , Ácidos Borónicos , Mieloma Múltiple/complicaciones , Mieloma Múltiple/terapia , Enfermedades del Sistema Nervioso Periférico , Pirazinas , Anciano , Antineoplásicos/efectos adversos , Antineoplásicos/uso terapéutico , Enfermedades Autoinmunes/inducido químicamente , Enfermedades Autoinmunes/etiología , Ácidos Borónicos/efectos adversos , Ácidos Borónicos/uso terapéutico , Bortezomib , Femenino , Humanos , Imagen por Resonancia Magnética , Mieloma Múltiple/diagnóstico , Mieloma Múltiple/tratamiento farmacológico , Trasplante de Células Madre de Sangre Periférica , Enfermedades del Sistema Nervioso Periférico/inducido químicamente , Enfermedades del Sistema Nervioso Periférico/diagnóstico , Enfermedades del Sistema Nervioso Periférico/etiología , Pirazinas/efectos adversos , Pirazinas/uso terapéutico , Trasplante Autólogo , Resultado del TratamientoRESUMEN
In MS patients with contraindications, intolerance, or failure of established immunomodulatory drugs, intravenous immunoglobulins (IVIG) are increasingly being administered. Several clinical studies recently showed that IVIG are generally safe, well tolerated and only occasionally have serious side effects. While some studies indicated beneficial effects from IVIG in relapsing-remitting MS, the recently published PRIVIG study failed to show any clinical benefit. Although pregnancy and the post-partum period appear to be interesting potential indications for IVIG, since under those conditions all other immunomodulatory drugs except for corticosteroids are not indicated, there are no data from adequate studies to support the use of IVIG in this patient group. For other indications in MS patients, study results are either negative or lacking. Overall IVIG may be considered a safe second-line compound in patients with relapsing-remitting MS. However, efficacy, long-term consequences, and optimal dosage of IVIG have not been unequivocally ascertained as yet.
Asunto(s)
Inmunoglobulinas/administración & dosificación , Inmunoglobulinas/efectos adversos , Esclerosis Múltiple/tratamiento farmacológico , Humanos , Factores Inmunológicos/administración & dosificación , Inyecciones Intravenosas , Resultado del TratamientoRESUMEN
Fulminant onset of neuropsychiatric symptoms as first manifestation of neuropsychiatric systemic lupus erythematosus (NPSLE) is rare and diagnosis is difficult if only one organ is involved. Here, we report the case of a previously healthy woman who presented with a clinical syndrome most compatible with acute onset of NPSLE. However, American College of Rheumatology (ACR) criteria were not sufficiently met. Brain biopsy showed an autoimmune complex vasculitis consistent with central nervous system (CNS) lupus. Because the prognosis of SLE-related CNS involvement is poor, aggressive immunosuppressive treatment was initiated using methylprednisolone in combination with cyclophosphamide.
Asunto(s)
Encéfalo/patología , Inmunosupresores/uso terapéutico , Vasculitis por Lupus del Sistema Nervioso Central/diagnóstico , Biopsia , Ciclofosfamida/uso terapéutico , Quimioterapia Combinada , Femenino , Humanos , Vasculitis por Lupus del Sistema Nervioso Central/tratamiento farmacológico , Vasculitis por Lupus del Sistema Nervioso Central/fisiopatología , Metilprednisolona/uso terapéutico , Persona de Mediana Edad , PronósticoRESUMEN
BACKGROUND: The diagnosis of multiple sclerosis (MS) is based on dissemination in space (DIS) and time (DIT). The aim of the study was to assess the impact of spinal cord (SC) imaging on the evidence of DIS and DIT. METHODS: Thirty-five treatment-naive patients with a first clinical symptom suggestive of MS were examined in a 2-year prospective longitudinal follow-up assessment. Brain and SC magnetic resonance imaging (MRI), Expanded Disability Status Scale and multiple sclerosis functional composite were analysed at baseline and after 1 and 2 years. RESULTS: At study entry, 21 patients were classified as clinically isolated syndrome suggestive of MS (CIS) and 14 patients as possible early MS. SC lesions were detected at baseline in 14 CIS patients (67%, median: 1.0, enhancing 29%) and in 11 patients with possible early MS (79%, median: 2.0, enhancing 29%). DIS as depicted by additive SC imaging was detected in two additional individuals according to the revised versus the 2001 McDonald criteria. All patients with emerging cord lesions showed new brain lesions. Five individuals developed clinically asymptomatic cord lesions. CONCLUSIONS: Spinal cord abnormalities are frequent in CIS patients and in patients with possible early MS. SC imaging slightly improved the establishment of DIS, but had no impact on the evidence of DIT.
Asunto(s)
Encéfalo/patología , Imagen por Resonancia Magnética/métodos , Esclerosis Múltiple/patología , Médula Espinal/patología , Adolescente , Adulto , Edad de Inicio , Biomarcadores , Encéfalo/fisiopatología , Evaluación de la Discapacidad , Progresión de la Enfermedad , Diagnóstico Precoz , Femenino , Estudios de Seguimiento , Humanos , Estudios Longitudinales , Imagen por Resonancia Magnética/normas , Masculino , Persona de Mediana Edad , Esclerosis Múltiple/fisiopatología , Valor Predictivo de las Pruebas , Pronóstico , Estudios Prospectivos , Médula Espinal/fisiopatología , Factores de Tiempo , Adulto JovenRESUMEN
We report the case history of a patient who suffered a subarachnoid hemorrhage (SAH) in association with early Lyme neuroborreliosis. After a tick bite, this patient developed erythema chronicum migrans and complained of stinging radicular pain in both legs. A computed tomography (CT) scan was performed because of acute headache and nuchal rigidity, which revealed an occipital SAH. Cerebrospinal fluid analysis provided further evidence of acute neuroborreliosis. Digital substraction angiography showed irregularities in the right posterior cerebral artery, which might be due to vasculitis, but no aneurysms.
Asunto(s)
Neuroborreliosis de Lyme/complicaciones , Hemorragia Subaracnoidea/microbiología , Vasculitis/complicaciones , Animales , Antibacterianos/uso terapéutico , Mordeduras y Picaduras , Cefuroxima/uso terapéutico , Angiografía Cerebral , Femenino , Humanos , Neuroborreliosis de Lyme/tratamiento farmacológico , Persona de Mediana Edad , Nimodipina/uso terapéutico , Hemorragia Subaracnoidea/líquido cefalorraquídeo , Hemorragia Subaracnoidea/etiología , Garrapatas , Vasculitis/tratamiento farmacológicoRESUMEN
Neurologic symptoms rarely occur as presenting feature of systemic lupus erythematosus (SLE). We describe a 37-year old woman who presented with several episodes of transverse myelitis and optic neuritis. Clinical, radiologic and laboratory findings were compatible with neuromyelitis optica (NMO). Seven years after disease onset clinical and laboratory findings were diagnostic for SLE. This case illustrates that NMO may represent a first manifestation of SLE for many years.
Asunto(s)
Lupus Eritematoso Sistémico/diagnóstico , Neuromielitis Óptica/etiología , Adulto , Femenino , Humanos , Lupus Eritematoso Sistémico/complicaciones , Mielitis Transversa/etiologíaRESUMEN
AIM: In addition to optic neuritis (ON), multiple sclerosis (MS) may also involve the eye with a typically bilateral intermediate uveitis. The aim of this pilot study was to evaluate the efficacy of type I interferons (IFN) for the treatment of MS associated uveitis. METHODS: In this non-randomised, retrospective observational case series 13 patients (eight female, five male) with proved MS and associated uveitis from five uveitis centres who were treated with interferon beta1a were included. Visual acuity (VA), cell count in the aqueous humour and vitreous, as well as the presence of cystoid macula oedema (CMO) were observed. RESULTS: All except one patient had a bilateral form of intermediate uveitis (total of 24 eyes). Seven patients had documented CMO before IFN treatment (n = 13 eyes). Median duration of treatment was 24.6 months (range 7.9-78.7). VA improved in 17 eyes (comparing VA before therapy and at last follow up); while 10 eyes (36%) improved >or=3 Snellen lines. Aqueous cell count improved by 1.2 (SD 1.1) grades in all eyes. Vitreous cell count improved by 1.7 (1.4) in all eyes. Only two patients still had minimal CMO on last follow up angiographically. CMO resolved after or during IFN treatment in nine eyes. CONCLUSIONS: IFN has been shown to have beneficial effects in patients with MS and/or ON. As shown in the models of experimental allergic encephalomyelitis (EAE) and uveitis, the neurological and ophthalmological manifestations seem to share similar pathogenic mechanisms. Treatment of MS associated uveitis with IFN appears to have beneficial effects on VA, intraocular inflammation activity, and the presence of CMO.
Asunto(s)
Interferón beta/uso terapéutico , Esclerosis Múltiple/complicaciones , Uveítis Intermedia/tratamiento farmacológico , Adulto , Femenino , Humanos , Factores Inmunológicos/uso terapéutico , Edema Macular/tratamiento farmacológico , Edema Macular/etiología , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Resultado del Tratamiento , Uveítis Intermedia/etiología , Uveítis Intermedia/fisiopatología , Agudeza Visual/efectos de los fármacosRESUMEN
Infectious diseases of the central nervous system have often to be considered in differential diagnosis, particularly in immunocompromised persons. Neuroimaging, specifically advanced techniques such as diffusion-weighted MRI and perfusion MRI contribute much to the differentiation of various brain infections and to delineation of brain infections from other, for instance, neoplastic diseases. In this review we present the imaging criteria for the most important brain infections in adults and discuss in detail differential diagnostic aspects.
Asunto(s)
Encefalopatías/diagnóstico por imagen , Encefalopatías/patología , Encéfalo/diagnóstico por imagen , Encéfalo/patología , Infecciones del Sistema Nervioso Central/diagnóstico por imagen , Infecciones del Sistema Nervioso Central/patología , Imagen por Resonancia Magnética/métodos , Tomografía Computarizada por Rayos X/métodos , Adulto , Diagnóstico Diferencial , Humanos , Guías de Práctica Clínica como Asunto , Pautas de la Práctica en MedicinaAsunto(s)
Síndrome de Chediak-Higashi/diagnóstico por imagen , Síndrome de Chediak-Higashi/fisiopatología , Dopamina/metabolismo , Neostriado/diagnóstico por imagen , Trastornos Parkinsonianos/diagnóstico por imagen , Sustancia Negra/diagnóstico por imagen , Adulto , Antiparkinsonianos/uso terapéutico , Síndrome de Chediak-Higashi/complicaciones , Humanos , Leucocitos/enzimología , Leucocitos/patología , Masculino , Neostriado/fisiopatología , Vías Nerviosas/fisiopatología , Trastornos Parkinsonianos/complicaciones , Trastornos Parkinsonianos/fisiopatología , Terminales Presinápticos/diagnóstico por imagen , Terminales Presinápticos/metabolismo , Terminales Presinápticos/patología , Sustancia Negra/fisiopatología , Transmisión Sináptica/genética , Tomografía Computarizada de Emisión de Fotón Único , Resultado del TratamientoRESUMEN
Postpolio syndrome is defined as a clinical syndrome of new pareses in individuals who had been affected by acute paralytic poliomyelitis years before. The objective of this study was to describe neurologic and psychiatric signs of the disease. We evaluated the clinical signs and treatment of 16 patients with postpolio syndrome. Possible symptoms of depression were evaluated by the Hamilton and Geriatric Depression Scales. Postpolio syndrome manifested at a median age of 57.5 years (range 25-73) in a median of 41 years (range 16-70 years) after acute poliomyelitis. Muscles already affected during acute poliomyelitis were affected in all patients with postpolio syndrome. Six of 16 patients (37.5%) developed paresis in muscles formerly not affected by acute poliomyelitis. In eight of 15 patients (53%), depressive episodes were recognized according to the ICD-10 criteria. Symptoms of depression should be recognized in patients with postpolio syndrome and incorporated in therapy based on physiotherapy.
Asunto(s)
Depresión/diagnóstico , Depresión/psicología , Síndrome Pospoliomielitis/diagnóstico , Síndrome Pospoliomielitis/psicología , Adulto , Anciano , Envejecimiento , Femenino , Humanos , Masculino , Persona de Mediana Edad , Pruebas Neuropsicológicas , Índice de Severidad de la EnfermedadRESUMEN
Immunocytoma (Waldenstrom's macroglobulinemia) is a rare chronic lymphoproliferative disorder of B-cell origin. It is characterized by the presence of large amounts of circulating monoclonal immunoglobulin M (IgM) and lymphoplasmocytoid bone marrow infiltration. Affection of the peripheral nervous system is common and causes polyneuropathy (5-10%). An isolated leptomeningeal infiltration by neoplastic cells is very rare and has been reported in few cases only. The diagnosis is difficult, in particular if cerebrospinal fluid (CSF) cytology is inconclusive. We present the case of a patient who developed a personality disorder and cognitive impairment. Initial CSF findings were compatible with chronic lymphocytic (aseptic) meningitis. The serologic detection of IgM paraproteinemia and bone marrow cytology suggested immunocytoma. The selective analysis of B-cell clonality in both whole CSF cell lysates and individual CSF cells using polymerase chain reaction (PCR) based amplification of the rearranged CDR3 region of the IgH gene revealed the presence of a monoclonal B-cell population and was diagnostic for leptomeningeal tumor cell infiltration by immunocytoma.
Asunto(s)
Neoplasias Meníngeas/complicaciones , Neoplasias Meníngeas/diagnóstico , Macroglobulinemia de Waldenström/diagnóstico , Macroglobulinemia de Waldenström/etiología , Anciano , Diagnóstico Diferencial , Progresión de la Enfermedad , Humanos , Masculino , Neoplasias Meníngeas/líquido cefalorraquídeo , Meningitis Aséptica/líquido cefalorraquídeo , Meningitis Aséptica/diagnóstico , Macroglobulinemia de Waldenström/líquido cefalorraquídeoAsunto(s)
Hemorragia/complicaciones , Hemorragia/diagnóstico , Paraplejía/diagnóstico , Paraplejía/etiología , Fenprocumón/efectos adversos , Enfermedades Vasculares de la Médula Espinal/complicaciones , Enfermedades Vasculares de la Médula Espinal/diagnóstico , Anciano , Diagnóstico Diferencial , Humanos , MasculinoAsunto(s)
Adrenoleucodistrofia/diagnóstico , Imagen por Resonancia Magnética , Adrenoleucodistrofia/diagnóstico por imagen , Adrenoleucodistrofia/epidemiología , Adrenoleucodistrofia/genética , Adrenoleucodistrofia/patología , Adrenoleucodistrofia/terapia , Adulto , Factores de Edad , Encéfalo/diagnóstico por imagen , Encéfalo/patología , Niño , Preescolar , Demencia/etiología , Diagnóstico Diferencial , Electroencefalografía , Epilepsia Tónico-Clónica/etiología , Humanos , Masculino , Fenotipo , Pronóstico , Cuadriplejía/etiología , Tomografía Computarizada por Rayos XRESUMEN
Although multiple sclerosis (MS) plaques, subacute cerebral ischaemic infarcts, focal vasogenic brain oedema, and subcortical arteriosclerotic encephalopathy (SAE) often have typical radiological patterns, they are sometimes difficult to distinguish from each other. Our aim was to determine whether they can be differentiated by magnetisation transfer (MT) measurements. We measured MT ratios (MTR) in ten patients with plaques of MS, 11 with subacute ischaemic infarcts, 12 with focal vasogenic oedema, and ten with lesions of SAE and compared the mean MTRs statistically. The MTR of normal white matter was 47.3%; the lowest MTR was found in plaques of MS (mean 26.4%). With the exception of vasogenic oedema and subacute cerebral ischaemic infarcts the mean MTRs were significantly different between all groups. MT measurements can provide additional information for the differentiation of these conditions, but we could not distinguish vasogenic oedema from subacute cerebral ischaemic infarcts.
Asunto(s)
Edema Encefálico/patología , Isquemia Encefálica/patología , Encéfalo/patología , Infarto Cerebral/patología , Arteriosclerosis Intracraneal/patología , Imagen por Resonancia Magnética , Esclerosis Múltiple/patología , Adulto , Diagnóstico Diferencial , Femenino , Humanos , Masculino , Persona de Mediana EdadRESUMEN
OBJECTIVES: To describe the clinical, CSF, and radiologic findings and long-term follow-up in a cohort of patients with acute disseminated encephalomyelitis (ADEM), and to determine possible prognostic factors for progression to MS. METHODS: Forty adults (28 women, mean age 33.5 years) diagnosed with ADEM were analyzed. Clinical symptoms, cranial MRI and CSF findings, and the response to a standardized treatment during the acute phase of the disease were analyzed by chart review. The final diagnosis of ADEM or clinically definite MS was established upon follow-up examination after 8 to 137 months. The patients with ADEM and MS were compared to detect differences between the two groups. RESULTS: Fifteen patients had a preceding infection (n = 14) or immunization (n = 1). The most frequent clinical signs were motor deficit (80%), followed by sensory deficits, brainstem signs, and ataxia. CSF findings were highly variable; normal results were present in 20% of patients. Oligoclonal bands were positive in 65% of patients. Ninety-five percent of all patients improved during the acute phase of the disease. Upon follow-up, 14 patients had developed clinically definite MS. Of the 26 patients with the final diagnosis of ADEM, two patients had died, nine had minor deficits, three had moderate deficits, and 12 patients had no remaining symptoms. Patients with the final diagnosis of ADEM were older, and more often had a preceding infection, clinical signs of brainstem involvement, a higher CSF albumin fraction, and infratentorial lesions. CONCLUSIONS: Many patients initially diagnosed with ADEM develop clinically definite MS upon long-term follow-up. The authors found no useful diagnostic criteria for the differentiation of a first episode of MS from monophasic ADEM. The term ADEM may still be employed as a description of a clinical syndrome, but should not be used as a distinct entity until reliable diagnostic criteria have been developed.
Asunto(s)
Encéfalo/patología , Encéfalo/fisiopatología , Encefalomielitis Aguda Diseminada/patología , Encefalomielitis Aguda Diseminada/fisiopatología , Adulto , Antiinflamatorios/uso terapéutico , Encéfalo/diagnóstico por imagen , Estudios de Cohortes , Ciclofosfamida/uso terapéutico , Diagnóstico Diferencial , Encefalomielitis Aguda Diseminada/líquido cefalorraquídeo , Femenino , Estudios de Seguimiento , Humanos , Inmunosupresores/farmacología , Imagen por Resonancia Magnética , Masculino , Metilprednisolona/uso terapéutico , Persona de Mediana Edad , Esclerosis Múltiple/líquido cefalorraquídeo , Esclerosis Múltiple/patología , Esclerosis Múltiple/fisiopatología , Pronóstico , Tomografía Computarizada por Rayos X , Resultado del TratamientoRESUMEN
Polymerase chain reaction (PCR) based automated high-resolution fragment analysis of rearranged immunoglobulin heavy-chain genes is a highly sensitive means for identifying clonal B-cell responses. We used this technique to distinguish polyclonal inflammatory from monoclonal neoplastic B-cell populations in the cerebrospinal fluid (CSF) of three patients with acute demyelinating disorders of the central nervous system whose clinical, magnetic resonance imaging (MRI) and CSF features did not permit unequivocal exclusion of primary central nervous system lymphoma (pC-NSL). This approach is highly suitable for detecting CNS inflammation particularly when lymphomatous involvement cannot be ruled out by noninvasive diagnostic procedures alone.
Asunto(s)
Neoplasias del Sistema Nervioso Central/líquido cefalorraquídeo , Neoplasias del Sistema Nervioso Central/genética , Enfermedades Desmielinizantes/líquido cefalorraquídeo , Enfermedades Desmielinizantes/genética , Linfoma/líquido cefalorraquídeo , Linfoma/genética , Enfermedad Aguda , Adulto , Linfocitos B/citología , Linfocitos B/fisiología , Neoplasias del Sistema Nervioso Central/fisiopatología , Regiones Determinantes de Complementariedad/líquido cefalorraquídeo , Regiones Determinantes de Complementariedad/genética , Regiones Determinantes de Complementariedad/fisiología , Enfermedades Desmielinizantes/fisiopatología , Electroforesis Capilar , Femenino , Humanos , Cadenas Pesadas de Inmunoglobulina/líquido cefalorraquídeo , Cadenas Pesadas de Inmunoglobulina/genética , Cadenas Pesadas de Inmunoglobulina/fisiología , Linfoma/fisiopatología , Masculino , Reacción en Cadena de la PolimerasaRESUMEN
Acute disseminated encephalomyelitis (ADEM) is an unusual demyelinating disease of the CNS. We review clinical symptoms, findings from radiological and CSF examinations, and current treatment strategies for ADEM. This disorder is often associated with a precedent infection or vaccination but may also occur spontaneously. The clinical symptoms are highly variable. Analysis of CSF usually reveals lymphocytic pleocytosis and an elevated protein content but may also yield normal results. Magnetic resonance imaging shows solitary or multiple lesions within the CNS. Most patients improve quickly with methylprednisolone. If that fails, immunoglobulin, plasmapheresis, or cytostatic drugs can be employed. Unlike MS, ADEM has a monophasic course and favourable long-term prognosis. Multiphasic courses are very rare. There are no diagnostic criteria to distinguish ADEM reliably from MS during the acute phase. We presume that ADEM is a variant of MS and not an independent disease entity.
Asunto(s)
Encéfalo/patología , Encefalomielitis Aguda Diseminada , Esclerosis Múltiple/diagnóstico , Adulto , Barrera Hematoencefálica , Descompresión Quirúrgica , Diagnóstico Diferencial , Encefalomielitis Aguda Diseminada/diagnóstico , Encefalomielitis Aguda Diseminada/patología , Encefalomielitis Aguda Diseminada/terapia , Femenino , Glucocorticoides/administración & dosificación , Humanos , Inmunoglobulinas/administración & dosificación , Leucocitosis/líquido cefalorraquídeo , Imagen por Resonancia Magnética , Masculino , Persona de Mediana Edad , Esclerosis Múltiple/clasificación , Plasmaféresis , Guías de Práctica Clínica como AsuntoRESUMEN
BACKGROUND: The goal of highly active antiretroviral therapy in HIV-infected patients is to reduce plasma viral load (VL) below quantifiable levels. Mutations associated with drug resistance within the HIV-1 genome can limit therapeutic success. Low VL implicates a low risk of emergence of resistant mutants. Whether there is divergent development of HIV strains in different biologic compartments is not understood. METHODS: The authors studied VL and the occurrence of mutations conferring resistance in viral genomes isolated from blood and CSF samples of 23 HIV-infected patients. They determined sequences of HIV-1 RNA by reverse transcriptase PCR amplification and direct sequencing. They measured resistance to antiretroviral drugs genotypically by detection of drug-related point mutations and VL by a branched-DNA assay. RESULTS: Amplification of HIV was successful even in patients with plasma or CSF VL below detection limit. VL was considerably lower in CSF as compared with blood (p < 0.0001). There was no correlation between CSF and plasma VL. The mutational pattern in viral copies derived from blood and CSF was not identical. Ten (9%) of the total number of 118 mutations associated with drug resistance occurred in blood isolates only; 14 (11%) were detected exclusively in CSF strains. CONCLUSION: There is evidence for viral replication at HIV RNA levels less than 50/mL. The results suggest divergent evolution of HIV-1 in different biologic compartments. The presence of resistant mutants in the CSF may escape regular diagnostic in blood. Therapeutic success may fail after adapting therapy to genotypic resistance patterns detected in one compartment only.
Asunto(s)
Terapia Antirretroviral Altamente Activa , Infecciones por VIH , Replicación Viral/genética , Adulto , Femenino , Infecciones por VIH/sangre , Infecciones por VIH/líquido cefalorraquídeo , Infecciones por VIH/tratamiento farmacológico , Infecciones por VIH/genética , Humanos , Masculino , Persona de Mediana Edad , Reacción en Cadena de la Polimerasa , Carga ViralRESUMEN
Two patients with acute disseminated encephalomyelitis after repeated injection of extracts from several different plants are described. There was no evidence of prior infection or vaccination. Both patients recovered rapidly after treatment with methylprednisolone. Acute disseminated encephalomyelitis should be considered a rare complication of parenteral therapy with herbal extracts.
Asunto(s)
Encéfalo/patología , Encefalomielitis Aguda Diseminada/etiología , Encefalomielitis Aguda Diseminada/patología , Fitoterapia , Adulto , Femenino , Humanos , Infusiones Parenterales , Imagen por Resonancia Magnética , Persona de Mediana EdadRESUMEN
The diagnosis of leptomeningeal B-cell lymphoma is based on the identification of malignant B cells in the cerebrospinal fluid (CSF). Frequently, cytology does not allow clear distinction between neoplastic lymphoid cells and reactively transformed mononuclear cells. Individual B-cell clones can be identified on the basis of DNA sequences that encode the highly diverse complementarity-determining region (CDR3) of the immunoglobulin heavy chain locus (IgH). We studied CSF samples from 5 patients with B-cell malignancies and cytological evidence of leptomeningeal involvement, using polymerase chain reaction (PCR)-based high-resolution capillary electrophoresis and automated fluorescence analysis to detect PCR fragments. As controls, we assessed CSF specimens from 7 patients with inflammatory neurological diseases and three samples without pathological findings. In all patients with B-cell malignancies, a single PCR product was generated, indicating that CDR3-specific fragments were derived from monoclonal cell populations. CSF samples from patients with inflammatory diseases yielded multiple CDR3 amplicons, suggesting the presence of a polyclonal B-cell activation. No PCR product could be amplified in normal CSF samples. Automated fluorescence detection of CDR3 fragments is a highly sensitive and rapid method to distinguish neoplastic monoclonal and reactive polyclonal B-cell populations in the CSF.